Advice Line with Serial Entrepreneur Mark Cuban - How I Built This with Guy Raz Recap

Podcast: How I Built This with Guy Raz

Published: 2026-01-29

Duration: 53 min

Summary

Mark Cuban discusses his efforts to revolutionize the prescription drug market through a robotics-driven manufacturing facility, addressing the challenges of high FDA fees and his motivation to lower drug prices for everyone.

What Happened

In this episode, Guy Raz is joined by Mark Cuban, a well-known entrepreneur and owner of the Dallas Mavericks, who shares insights into his latest venture aimed at transforming the prescription drug industry. Cuban has established a robotics-driven manufacturing facility in Dallas that focuses on producing sterile injectables. He emphasizes the need for affordable and accessible prescription drugs, especially given the current shortages affecting hospitals.

Cuban highlights the significant challenges posed by FDA fees, which can cost millions for multiple drug applications. He points out that while they can produce generic drugs more cheaply in the U.S. than importing them from countries like India or China, the regulatory costs are a major barrier. Cuban is actively engaging with the FDA to advocate for waiving these fees, believing that a favorable response could enable them to scale production significantly within just a year.

Throughout the conversation, Cuban’s motivation shines through. He is driven by a desire to fix the economic side of healthcare for everyone, stating, "Everybody hates the economic side of their healthcare. Everybody. I want to fix that." His competitive spirit and curiosity keep him engaged in learning about the medical system and its challenges, as he aspires to leave a legacy of improving healthcare for future generations.

Key Insights

Key Questions Answered

What is Mark Cuban's approach to prescription drug manufacturing?

Mark Cuban has established a robotics-driven manufacturing facility in Dallas, Texas, focusing on producing sterile injectables. This facility aims to address the critical shortages of certain drugs, particularly those in high demand for hospitals. Cuban’s approach leverages advanced robotics to efficiently produce medications, allowing for rapid changes in production to meet fluctuating needs.

How do FDA fees impact drug production in the U.S.?

Cuban highlights the substantial financial burden posed by FDA fees, which can reach $365,000 for each new drug application. For companies like his that aim to produce hundreds or thousands of generics, these fees can accumulate to tens of millions of dollars, making it economically challenging to manufacture drugs domestically. This regulatory environment discourages many from pursuing U.S.-based production.

What motivates Mark Cuban to invest in healthcare?

Cuban is motivated by a deep-seated desire to improve the healthcare system, particularly regarding drug pricing. He expresses frustration about the economic aspects of healthcare that negatively impact individuals. His mission goes beyond profit; he aims to create a legacy of accessibility and affordability in prescription medications that benefits everyone.

What challenges does Cuban face in his drug pricing initiative?

One of the primary challenges Cuban faces is the high cost of regulatory compliance with the FDA. He notes that while they can manufacture drugs at a lower cost domestically compared to overseas production, the associated fees hinder their ability to scale effectively. Engaging with the FDA to seek changes in these regulations is crucial for the success of his initiative.

How does Cuban plan to scale his drug manufacturing operations?

Cuban believes that if the FDA waives the regulatory fees, his facility can quickly ramp up production within about 12 months. His innovative approach includes a modular manufacturing system that can be transported and set up wherever needed, allowing for localized drug production. This flexibility is essential for addressing drug shortages efficiently.